PRESS RELEASE published on 02/23/2026 at 15:24, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.24% stake in Bluefield Solar Income Fund. Form 8.3 revealing position held on 20 February 2026 Form 8.3 Position Disclosure Vanguard Group Stake Disclosure Bluefield Solar Income Fund
PRESS RELEASE published on 02/23/2026 at 15:23, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc with 30,156,894 securities purchased at 12.19 GBP per unit on 20 Feb 2026 The Vanguard Group, Inc. Ownership Disclosure Securities Purchase Beazley Plc GBP 12.19
PRESS RELEASE published on 02/23/2026 at 15:21, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. files Form 8.3 disclosing 2.51% ownership in Schroders plc on 20 Feb 2026. Purchase of 16,023 20p ordinary shares at 5.86 GBP per unit Form 8.3 Schroders Plc Vanguard Group Ownership Disclosure Share Purchase
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc as of 20 February 2026 through Form 8.3 filing Form 8.3 Disclosure Vanguard Group Spire Healthcare Stake
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses 1% ownership of Oxford Biomedica plc securities as of 20th Feb 2026. Details in Form 8.3 filing Form 8.3 Vanguard Group Ownership Disclosure Financial Securities Oxford Biomedica
PRESS RELEASE published on 02/23/2026 at 15:19, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses ownership of 4.92% in Just Group plc's 10p ordinary securities. Form 8.3 filed under Takeover Code Rule 8.3 The Vanguard Group, Inc. Form 8.3 Takeover Code Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/23/2026 at 15:18, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.29% stake in LondonMetric Property plc. Positions and dealings detailed as per Form 8.3 disclosure requirements LondonMetric Property Plc The Vanguard Group Financial Holdings Form 8.3 Disclosure Stock Transactions
PRESS RELEASE published on 02/23/2026 at 15:17, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses holding 1.12% of International Personal Finance plc's securities. Form 8.3 filed on 23-Feb-2026 Form 8.3 Securities Disclosure Vanguard Group Financial Holdings International Personal Finance Plc
PRESS RELEASE published on 02/23/2026 at 15:17, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses holding 4.82% stake in NCC Group plc as of 20th Feb 2026. Sale of 1p ordinary shares at 1.33 GBP per unit The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Share Sale NCC Group Plc
PRESS RELEASE published on 02/23/2026 at 15:16, 6 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. discloses a 5.44% interest in British Land Company plc. Form 8.3 filing under Rule 8.3 of the Takeover Code on 23-Feb-2026 The Vanguard Group Rule 8.3 Takeover Code Form 8.3 Filing British Land Company Plc
Published on 09/11/2026 at 04:00, 7 hours 36 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 11 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 16 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 36 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 1 hour 21 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 2 hours 16 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 31 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 36 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 36 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 36 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 36 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 6 minutes ago Availability of the 2026 Interim Financial Report
